resveratrol has been researched along with lysophosphatidylcholines in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baolin, L; Jinghua, F; Junna, S; Kang, L; Lin, L; Min, Z | 1 |
Cao, X; Chen, J; Cui, Y; Zeng, G; Zhang, G | 1 |
2 other study(ies) available for resveratrol and lysophosphatidylcholines
Article | Year |
---|---|
Resveratrol restores lysophosphatidylcholine-induced loss of endothelium-dependent relaxation in rat aorta tissue coinciding with inhibition of extracellular-signal-regulated protein kinase activation.
Topics: Animals; Aorta, Thoracic; Biological Factors; Cells, Cultured; Cyclooxygenase 1; Endothelial Cells; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Gene Expression Regulation; Humans; In Vitro Techniques; Lysophosphatidylcholines; Male; Membrane Proteins; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2010 |
Resveratrol alleviates lysophosphatidylcholine-induced damage and inflammation in vascular endothelial cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Cell Line; DNA, Complementary; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-6; L-Lactate Dehydrogenase; Lysophosphatidylcholines; Models, Cardiovascular; Myeloid Differentiation Factor 88; NF-kappa B; Resveratrol; RNA, Small Interfering; Signal Transduction; Stilbenes; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2018 |